These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 37663132)

  • 1. Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives.
    Yue NN; Xu HM; Xu J; Zhu MZ; Zhang Y; Tian CM; Nie YQ; Yao J; Liang YJ; Li DF; Wang LS
    Mol Ther Oncolytics; 2023 Sep; 30():193-215. PubMed ID: 37663132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects.
    Suri C; Pande B; Sahu T; Sahithi LS; Verma HK
    J Clin Med; 2024 Jul; 13(13):. PubMed ID: 38999541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders.
    Aljeradat B; Kumar D; Abdulmuizz S; Kundu M; Almealawy YF; Batarseh DR; Atallah O; Ennabe M; Alsarafandi M; Alan A; Weinand M
    Pathophysiology; 2024 May; 31(2):244-268. PubMed ID: 38804299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders.
    Mittal R; Patel AP; Jhaveri VM; Kay SS; Debs LH; Parrish JM; Pan DR; Nguyen D; Mittal J; Jayant RD
    Expert Opin Drug Deliv; 2018 Mar; 15(3):301-318. PubMed ID: 29272976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies.
    Singh D
    AAPS PharmSciTech; 2024 Jun; 25(5):129. PubMed ID: 38844700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics.
    Prajapati RN; Bhushan B; Singh K; Chopra H; Kumar S; Agrawal M; Pathak D; Chanchal DK; Laxmikant
    Curr Pharm Biotechnol; 2024; 25(16):2060-2077. PubMed ID: 38288793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnology.
    Carvalho C; Lemos L; Antas P; Seabra MC
    Front Ophthalmol (Lausanne); 2023; 3():1270561. PubMed ID: 38983081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for polygenic or complex diseases.
    Wu T; Hu Y; Tang LV
    Biomark Res; 2024 Sep; 12(1):99. PubMed ID: 39232780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles as Drug Delivery System for Cancer Therapy.
    Wang J; Yin B; Lian J; Wang X
    Pharmaceutics; 2024 Aug; 16(8):. PubMed ID: 39204374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancements in Hematopoietic Stem Cell Gene Therapy: A Journey of Progress for Viral Transduction.
    Giommetti A; Papanikolaou E
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective therapeutic targets and recent advancements in the treatment of inflammatory bowel disease.
    Sinha A; Roy S
    Immunopharmacol Immunotoxicol; 2024 Aug; 46(4):550-563. PubMed ID: 39013809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives.
    Huang C; Li Q; Li J
    Med Rev (2021); 2022 Oct; 2(5):471-500. PubMed ID: 37724161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging strategies for treating autoimmune disease with genetically modified dendritic cells.
    Ma Y; Shi R; Li F; Chang H
    Cell Commun Signal; 2024 May; 22(1):262. PubMed ID: 38715122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disorders: gene therapy solutions.
    Wirtz S; Neurath MF
    Curr Opin Mol Ther; 2003 Oct; 5(5):495-502. PubMed ID: 14601518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insect pathogens as biological control agents: Back to the future.
    Lacey LA; Grzywacz D; Shapiro-Ilan DI; Frutos R; Brownbridge M; Goettel MS
    J Invertebr Pathol; 2015 Nov; 132():1-41. PubMed ID: 26225455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives.
    Dos Santos AM; Carvalho SG; Meneguin AB; Sábio RM; Gremião MPD; Chorilli M
    J Control Release; 2021 Jun; 334():353-366. PubMed ID: 33901582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of nanomedicine in optimising the treatment of inflammatory bowel disease.
    Mohan LJ; Daly JS; Ryan BM; Ramtoola Z
    Scand J Gastroenterol; 2019 Jan; 54(1):18-26. PubMed ID: 30678499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advancements and prospective developments in anti-tumor targeted therapy.
    Leng G; Duan B; Liu J; Li S; Zhao W; Wang S; Hou G; Qu J
    Neoplasia; 2024 Oct; 56():101024. PubMed ID: 39047659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.